Aarey Drugs & Pharmaceuticals Limited (NSE:AAREYDRUGS)

Market Cap	2.90B +29.1%
Revenue (ttm)	4.15B -7.7%
Net Income	36.20M -12.9%
EPS	1.27 -14.0%
Shares Out	n/a
PE Ratio	80.19
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,534
Open	101.75
Previous Close	102.63
Day's Range	99.81 - 101.78
52-Week Range	50.31 - 103.99
Beta	1.25
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About NSE:AAREYDRUGS

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 132
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AAREYDRUGS

Financial Performance

In fiscal year 2026, NSE:AAREYDRUGS's revenue was 4.72 billion, a decrease of -0.35% compared to the previous year's 4.74 billion. Earnings were 39.68 million, a decrease of -1.40%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 24, 2026

Data Sources Report a data error